Pfizer to cut jobs at Manitoba PMU plant

Byproduct foals from Premarin industry in slaughter feedlot.

Pharma giant says decision won't affect its PMU ranchers Alberta Farm Express reports: Drugmaker Pfizer's restructuring of its estrogen extraction plant at Brandon, Man[itoba] calls for about 40 per cent fewer employees by the end of next year. The company processes conjugated estrogen from pregnant mares' urine (PMU) at Brandon to make the hormone replacement… Continue reading Pfizer to cut jobs at Manitoba PMU plant

Wyeth wins, horses lose, in the Premarin® drug sales sweepstakes

Written by JANE ALLIN Research Analyst | Int'l Fund for Horses Since the introduction of Premarin in 1942, much controversy has followed the lucrative market monopoly of the world’s first conjugated equine estrogen therapy for the treatment of postmenopausal women. Historically, the number of PMU farms, sequestered mares and by-product foals steadily rose until the… Continue reading Wyeth wins, horses lose, in the Premarin® drug sales sweepstakes

Join the ladies in the Bar-P Lounge for a shot of PMU

Help Save Women, the Mares and the Foals Advise your treating physicians about the cruelty to the mares and foals, and dangers to women -- and men too -- who take the Premarin family of drugs. --> Watch this video and rate it 5 stars to help give it more visibility on YouTube. --> Share… Continue reading Join the ladies in the Bar-P Lounge for a shot of PMU

Pfizer Wyeth merger worries PMU producers (US/CAN)

AN AGREEMENT that will see pharmaceutical giant Pfizer take over rival company Wyeth for $68 billion has caused some uncertainty for pregnant mare's urine producers in Sask, Man. and in North Dakota. Norm Luba , executive director of The North American Equine Ranching Information Council (NAERIC) said there are 71 PMU farms in Western Canada… Continue reading Pfizer Wyeth merger worries PMU producers (US/CAN)